Related Experiment Video
Updated: Feb 1, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Drug therapy for renal cell carcinoma in the elderly
Abstract:
The incidence of renal cell carcinoma (RCC) peaks between 60 and 70 years, and > 25% of newly diagnosed patients are > 75 years. However, clinical trials for the evaluation of drug therapy for metastatic RCC (mRCC) have generally under-represented the actual proportion of elderly patients in the general population of mRCC patients; therefore, limited data remain available with respect to the efficacy as well as safety of drug therapy for elderly mRCC pa- tients. In this review, therefore, we attempted to summarize the current status of drug ther- apy for mRCC in the elderly based on both the available findings as well as our experience, and to discuss the future prospect of this therapy considering characteristics specific to eld- erly mRCC patients.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Drug Therapy
Antianxiety Medications
Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Drug Elimination: Non-Renal Routes
Renal Drug Excretion: Overview
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...

